Saquinavir: an HIV proteinase inhibitor.
Bragman
K
K
Roche International Clinical Research Centre, Parc Club des Tanneries, Lingolsheim, France.
D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects; D015498:HIV-2 / Q000187:drug effects; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D019258:Saquinavir
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D019258:Saquinavir